Equity Overview
Price & Market Data
Price: $0.0055
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $3,507
Daily Volume: 0
Performance Metrics
1 Week: -92.14%
1 Month: -89.00%
3 Months: -93.89%
6 Months: -97.22%
1 Year: -97.38%
YTD: -93.13%
Company Details
Employees: 39
Sector: Health technology
Industry: Biotechnology
Country: United Kingdom
Details
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.